Neurotechnology
Resleeving (transferring a mind into a new body)
Installing a stored mind into a different body, biological or cloned, so a person wakes up intact in unfamiliar flesh.
In shortResleeving (transferring a mind into a new body), from Altered Carbon (Richard K. Morgan, 2002), is at technology readiness level 1 of 9 (basic principles observed) at its weakest link. Held back by Writing a stored mind into a new nervous system. Science status: requires unconfirmed physics or an open scientific question with no known path to answer. Estimated new funding to unlock: $43B–247B (a floor; some parts are priced only to early research).
Takeshi Kovacs is downloaded from storage into a stranger's confiscated body, and later into a clone, suffering disorientation while his mind adapts to new neurochemistry.
Closest todayNone. Partial analogues are BCI users learning to control robotic limbs and single artificial memories installed in mice.
Dependency stack
Research TRL 1–3Development TRL 4–6Deployment TRL 7–9
Sort by
- The stored state must be written into a nervous system that already has its own structure
- No mechanism to set ~1e14 synaptic weights in a living brain
- A host brain already has its own structure and memories that would have to be overwritten
- Body schema mismatch; sensorimotor maps are body-specific and take months to adapt
- Whether a written state would be the same person is untestable with present methods
speculativeTRL 1- You cannot write a state you cannot specify
✕3 blockers›
- Unknown which molecular species are sufficient to infer functional synaptic weight
- Antibody or barcode multiplexing depth, and uniform labeling across centimetre-scale tissue
- Fixation chemistry that preserves both ultrastructure and labile post-translational state
plausibleTRL 2- Theory decides which molecular variables must be measured at all
✕1 blocker›
- Unknown sufficient level of biological detail
plausibleTRL 2- Wiring diagrams constrain and test circuit models
✕3 blockers›
- Human proofreading of AI segmentation dominates cost; 2025 methods imply tens of billions of dollars for one mouse brain
- Imaging throughput and storage; a human brain at EM resolution is of order 100+ exabytes of raw data
- Sectioning or expanding whole large brains without tissue loss or distortion
TRL 3- Ultrastructure must survive preservation before it can be imaged
✕3 blockers›
- Ischemic damage starts within minutes of circulatory arrest, before perfusion can begin
- Aldehyde fixation may destroy molecular state (phosphorylation, receptor conformation) that could carry memory
- No assay proves preserved tissue still contains the information an emulation would need
TRL 4 - Automated segmentation and tracing of exabyte-scale image volumes
✕2 blockers›
- Grid power and interconnection queues
- Advanced-node chip and HBM memory supply
TRL 8
- Molecular readout is only useful registered to every traced synapseTRL 3
- A stored mind must first be captured and represented
✕3 blockers›
- Unknown sufficient level of detail; no accepted criterion for when an emulation is the same person
- Static connectomes lack synaptic weights, neuromodulatory state and glial contributions
- Validation problem; without the original brain's activity you cannot check the copy
plausibleTRL 2- Wiring without weights and molecular state does not specify a mindplausibleTRL 2
- Determines which biological detail must be simulated for cognition to appearplausibleTRL 2
- Activity from the source brain is the only way to validate the emulation
✕3 blockers›
- Optical methods cannot penetrate a human skull or image below ~1 mm of tissue
- Channel count, heat dissipation and uplink bandwidth for ~86 billion neurons
- Displaced tissue volume and vascular damage scale with the number of inserted probes
plausibleTRL 2- Whole-brain coverage needs sensors orders of magnitude smaller than current shanks
✕3 blockers›
- No scheme to individually power and address millions of untethered sub-cellular devices
- Egress bandwidth; nanoparticles can stimulate but cannot yet report spikes off-board
- Clearance, aggregation and long-term toxicity of persistent intraparenchymal devices
plausibleTRL 3- Non-surgical delivery requires crossing from blood into brain parenchyma
✕3 blockers›
- Receptor targeting is species-specific; capsids binding human TfR1 often fail in macaque
- Pre-existing anti-AAV immunity excludes a large fraction of patients and blocks redosing
- Dose needed for brain-wide coverage drives liver toxicity and manufacturing cost
TRL 4- Designed capsid and shuttle proteins are the main route to receptor-specific transcytosis
✕1 blocker›
- Designing catalysis and conformational dynamics
TRL 6
- Devices resident in tissue for decades must not provoke encapsulation
✕3 blockers›
- Micromotion between rigid device and pulsating tissue drives chronic inflammation
- Thin-film encapsulation (polyimide, parylene, SiC) eventually admits water and fails
- Electrode charge-injection limits and corrosion under years of continuous stimulation
TRL 4
- Recording must remain stable for the duration of a life, not monthsTRL 4
- Electrode arrays are today's only route to single-neuron recording in humans
✕2 blockers›
- Tissue response degrades signal over years
- Channel count and wireless bandwidth
TRL 6- Channel count is limited by wireless data and power budget
✕3 blockers›
- Tissue heating caps implant power at a few hundred milliwatts, which bounds radio and compute
- Raw broadband neural data exceeds the link, forcing on-implant spike detection and compression
- Battery or wireless-power lifetime versus the decades a permanent interface implies
TRL 5- Implant power density sets what telemetry and on-board compute are affordable
✕2 blockers›
- Cycle life of lithium-metal anodes
- Thermal runaway safety
TRL 6
- An individual's wiring diagram is the irreducible inputTRL 3
- Running the model at biological speed requires brain-scale compute
✕3 blockers›
- Synaptic state alone needs petabytes of high-bandwidth memory, which dominates cost
- All-to-all spike traffic makes the problem interconnect-bound, not FLOP-bound
- Energy per synaptic event is ~1e6 times worse than biology, so a real-time human emulation implies large power draw
TRL 4- The same accelerator, power and interconnect supply chain is the base for brain-scale machinesTRL 8
- Writing synapse-by-synapse requires access at cellular scale throughout the brainplausibleTRL 3
- There must be a complete, re-instantiable representation of the mind to installplausibleTRL 2
- Growing replacement bodies on demand without a human gestational carrier
✕3 blockers›
- The gap between day-14 embryo culture and artificial-placenta viability covers organogenesis, the hardest and least substitutable phase
- No artificial implantation or placental organ exists to supply hormones and nutrient exchange during that gap
- Scaling implies thousands of parallel units with sterility and uninterrupted power for nine months each
TRL 2- The early half cannot be built without reconstructing implantation and placental exchange
✕3 blockers›
- The placenta's endocrine and nutrient-exchange functions have not been reproduced by any device or culture
- Maternal immune tolerance at the interface is not understood well enough to substitute for
- Human implantation cannot be studied past the 14-day limit, so the critical window is inaccessible
TRL 3 - An engineered placenta is a vascularized tissue that must be grown, not just machined
✕4 blockers›
- Capillary-scale perfusion cannot be printed and must self-assemble, which is uncontrolled today
- Printed tissue must mature into function (filtration, metabolism, contraction), and maturation protocols stall at fetal-like performance
- Cell demand of 10^10-10^11 per organ exceeds current manufacturing
- Mechanical integration - ureters, bile ducts, valves - has no demonstrated fabrication route
TRL 4- Without a capillary network, tissue thicker than a few hundred microns dies
✕3 blockers›
- Printing resolution stops at tens of microns while capillaries are 5-10 microns, so the smallest and most numerous vessels must self-assemble
- Engineered endothelium is thrombogenic, so perfused constructs clot
- No method guides anastomosis of a construct's vasculature to host vessels at scale
TRL 3 - Banked-cell organs are not patient-matched, so acceptance must be engineered
✕3 blockers›
- Chronic antibody-mediated rejection proceeds even under current immunosuppression
- Tolerance protocols trade rejection risk for conditioning toxicity and graft-versus-host disease
- No assay predicts which recipients can be safely weaned off drugs
TRL 5 - One organ needs 10^10-10^11 clinical-grade cells of several types
✕3 blockers›
- Genomic instability and drift accumulate over the expansion needed for 10^11 cells
- Each organ needs many cell types differentiated on a synchronized schedule, not one lineage
- Cost per cell at current media and reagent prices makes a printed organ unaffordable
TRL 6
- Supplies the late-gestation half of the problem
✕4 blockers›
- Miniaturization - the lamb model weighs 1-3 kg while a 23-week human fetus is about 500 g, with shorter umbilical cannulation distances
- Umbilical vessel vasospasm and thrombosis during cannulation and over weeks of support
- Infection control in a continuously exchanged sterile fluid environment
- No agreed proof-of-concept endpoint or animal model that maps onto human neonatal outcomes
TRL 5- Sterile fluid exchange, nutrition and waste handling must run continuously without interruption
✕2 blockers›
- Food production closure
- Microbial and ecological stability over years
TRL 5 - Gas exchange through the umbilical circuit for weeks is the core function
✕3 blockers›
- Blood-surface contact activates coagulation, so runs depend on anticoagulation that causes bleeding in fragile patients
- Oxygenator plasma leakage and fiber fouling limit single-circuit life
- Hemolysis and platelet consumption scale with pump shear and circuit length
TRL 7
- Writing a state into every synapse of a host brain needs cell-scale access throughout itplausibleTRL 3
- Clone sleeves require producing a genetically identical body
✕3 blockers›
- Incomplete epigenetic reprogramming of the donor nucleus produces placental defects and large-offspring syndrome
- Efficiency is a few percent of transferred embryos, so each live birth consumes many donor eggs and surrogates
- Donor egg supply is the limiting input for any primate-scale program
TRL 5
Who could unlock it
- Across several requirements:
- Eon Systems 2
- Carboncopies Foundation 2
Writing a stored mind into a new nervous systemTRL 1bottleneck
- Eon SystemsStartupRan a whole fly-brain emulation in a simulated body (2026), the closest current work to running a captured brain state in a body; raised a $3.5M seed
- Carboncopies FoundationProgramNon-profit roadmapping whole-brain emulation, including restorative neuroprosthetic transfer and an ethics framework (2025)
- Sheena JosselynResearcher, SickKids and University of TorontoCreated memories in mice without experience by artificially linking engram ensembles (Nature Neuroscience 2019)
- Steve RamirezResearcher, Boston UniversityArtificial activation and editing of specific engrams in mice
Whole-brain emulationTRL 2
- Eon SystemsStartupRan a FlyWire-based whole fly brain emulation driving a MuJoCo body through multiple behaviors (2026); targeting a mouse emulation
- Philip ShiuResearcher, Eon SystemsAuthor of the whole Drosophila brain computational model (Nature 2024) and co-author of the State of Brain Emulation Report 2025
- Carboncopies FoundationProgramNon-profit coordinating WBE research, a Brain Emulation Challenge and an emulation ethics framework (2025)
- HHMI Janelia FlyEMAcademic labPublished the complete Drosophila central nervous system connectome (2025-2026), the data emulations depend on
Full-term ectogenesisTRL 2
- Jacob HannaResearcher, Weizmann Institute of ScienceGrew natural mouse embryos ex utero from E5.5 to E11 through organogenesis (Nature, 2021) and generated transgene-free post-gastrulation whole embryo models from naive stem cells (Cell Stem Cell, 2025); holds an ERC grant titled ExUteroEmbryogenesis
- Alejandro Aguilera-CastrejonResearcher, Janelia Research Campus, HHMIBuilt the roller and perfusion ex utero culture platform in the Hanna lab and now works explicitly toward birthing a mouse from an incubator
- Renewal BioStartupIsraeli company co-founded by Hanna in 2022 that licensed the Weizmann ex utero and synthetic-embryo patents (about $9M raised via NFX) to grow early tissue as a cell source
- Vitara BiomedicalStartupWorking the opposite end of the same problem - fluid-filled support from roughly 22 weeks of human gestation onward, the only part of full-term ectogenesis anywhere near clinical use
Injectable and self-implanting nanoscale neural interfacesTRL 3
- Deblina SarkarResearcher, MIT Media LabCirculatronics: immune-cell-electronics hybrids injected into the blood self-implanted in a target mouse brain region and were wirelessly powered (Nature Biotechnology 2025)
- Jacob RobinsonResearcher, Rice UniversityMagnetoelectric wireless power for distributed battery-free implant networks (Nature Biomedical Engineering 2025)
- Jia LiuResearcher, Harvard SEASCo-inventor of syringe-injectable mesh electronics; 2025 Nature Electronics paper on wireless ultrathin brain interfaces
- SynchronStartupEndovascular Stentrode in 10 patients by 2025; developing a transcatheter high-channel whole-brain interface
Somatic cell nuclear transfer cloningTRL 5
- Qiang SunResearcher, Institute of Neuroscience, Chinese Academy of SciencesCloned the macaques Zhong Zhong and Hua Hua (2018) and ReTro, the first cloned rhesus to reach adulthood, using trophoblast replacement (2024)
- Institute of Neuroscience, Chinese Academy of SciencesGovernment labThe only group to have produced primate clones; its 2024 result consumed 113 transferred embryos for one surviving animal
- ViaGen Pets and EquineCompanyThe commercial SCNT operation, cloning cats, dogs and horses and the Przewalski's horse Kurt; acquired by Colossal Biosciences in November 2025
- Colossal BiosciencesStartupUses cloning from edited cell lines as its route to live animals and bought ViaGen in 2025 to bring that throughput in-house
Beyond engineering
- Bodies as transferable property and the market in sleeves
- Whether the person who wakes up is legally and morally the same person